Groups
|
Body weight (g)
|
Splenomegaly (g)
|
Tumor volume (mL)
|
Packed cell volume (mL)
|
Viable tumor cell count (×106 cells/mL)
|
---|
Control L5178Y
|
30.83 ± 2.41
|
0.23 ± 0.05
|
2.67 ± 1.08
|
1.30 ± 0.49
|
412.62 ± 35.14
|
L5178Y + Globulin UF
|
29.32 ± 2.89
|
0.23 ± 0.11
|
3.00 ± 1.22
|
1.12 ± 0.87
|
286.96 ± 92.84
|
L5178Y + Glutelin UF
|
27.5 ± 1.73
|
0.19 ± 0.02
|
4.20 ± 0.64 *
|
1.97 ± 0.60
|
415.80 ± 92.88
|
L5178Y + Albumin SFD
|
28.08 ± 2.38
|
0.20 ± 0.07
|
0.60 ± 0.75 *
|
0.50 ± 0.30 *
|
750.00 ± 47.03 *
|
L5178Y + Glutelin SFD
|
31.06 ± 3.20
|
0.21 ± 0.01
|
3.50 ± 3.46
|
1.02 ± 0.95
|
365.10 ± 223.82
|
- Non-lethal oral dose of 25 mg/Kg/day during 15 - 17 days, after inoculation of 6 × 104 lymphoma L5178Y cells/mL per mice
- Data are expressed as the mean of the results of two experiments with n = 5 in each experiment ± S.E.M.
- * p < 0.05 extract-treated groups compared with the lymphoma L5178Y control group
- Body weight of normal mice: 23.50 ± 1.59 g. Spleen weight of normal mice: 0.12 ± 0.04 g.